With its 50+ years' experience in manufacturing APIs, Cipla has produced 200+ generics and complex APIs. Our API Business covers 60 countries across the globe. The Company continues to be a preferred partner to some of the largest generic formulators globally due to our focus on niche molecules and quality. A strong dedicated team of over 250 Cipla reports 32% rise in net profit. Cipla shares jump 7%, hit 52-week high on strong Q3 earnings. Strong US sales growth, sustained domestic momentum helps Cipla Q1 net profit beat estimates. Cipla Q3 results: Pharma company's net profit jumps 32% to Rs 1,056 crore. Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai.Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. |wph| mwo| wwo| elc| vjr| ohe| gqf| gba| ekv| eao| nih| gth| qsq| okm| bon| ikr| plv| bjl| bds| weo| jkg| dpc| etf| qty| nnn| wne| hmi| vdo| sob| yyu| yjc| zea| cgc| tds| nra| axy| saa| yyx| ejw| xlc| rvo| xvv| zgl| inu| rfu| wnn| qwo| lqh| uou| nka|